15-Deoxy-Δ12,14-prostaglandin J2 Induces Epithelial-tomesenchymal Transition in Human Breast Cancer Cells and Promotes Fibroblast Activation

다국어 초록 (Multilingual Abstract)

In inflammation-associated carcinogenesis, COX-2 is markedly overexpressed, resulting in accumulation of various prostaglandins.
15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) is one of the terminal products of COX-2-catalyzed arachidonic acid catabolism with oncogenic potential. Epithelial-to-mesenchymal transition (EMT) is a process by which epithelial cells lose their polarity and adhesiveness, and thereby gain migratory and invasive properties. Treatment of human breast cancer MCF-7 cells with 15d-PGJ2 induced EMT as evidenced by increased expression of Snail and ZEB1, with concurrent down-regulation of E-cadherin. Nuclear extract from 15d-PGJ2-treated MCF-7 cells showed the binding of Snail and ZEB1 to E-box sequences present in the E-cadherin promoter, which accounts for repression of E-catherin expression. Unlike 15d-PGJ2, its non-electrophilic analogue 9,10-dihydro- 15d-PGJ2 failed to induce EMT, suggesting that the α,β-unsaturated carbonyl group located in the cyclopentenone ring of 15d-PGJ2 is essential for its oncogenic function. Notably, the mRNA level of interleukin-8 (IL-8)/CXCL8 was highly elevated in 15d-PGJ2-stimulated MCF-7 cells. 15d-PGJ2-induced up-regulation of IL-8/CXCL8 expression was abrogated by silencing of Snail short interfering RNA. Treatment of normal fibroblast with conditioned medium obtained from cultures of MCF-7 cells undergoing EMT induced the expression of activated fibroblast marker proteins, α-smooth muscle actin and fibroblasts activation protein-α.
Co-culture of normal fibroblasts with 15d-PGJ2-stimulated MCF-7 cells also activated normal fibroblast cells to cancer associated fibroblasts. Taken together, above findings suggest that 15d-PGJ2 induces EMT through up-regulation of Snail expression and subsequent production of CXCL8 as a putative activator of fibroblasts, which may contribute to tumor-stroma interaction in inflammatory breast cancer microenvironment.

참고문헌 (Reference)

1 Moreno-Bueno G, "Transcriptional regulation of cell polarity in EMT and cancer" 27 : 6958-6969, 2008

2 Sporn MB, "The war on cancer" 347 : 1377-1381, 1996

3 Dannenberg AJ, "The role of COX-2 in breast and cervical cancer" 37 : 90-106, 2003

4 Li L, "The invasive potential of human melanoma cell lines correlates with their ability to alter fibroblast gene expression in vitro and the stromal microenvironment in vivo" 125 : 1796-1804, 2009

5 De Wever O, "Stromal myofibroblasts are drivers of invasive cancer growth" 123 : 2229-2238, 2008

6 Orimo A, "Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion" 121 : 335-348, 2005

7 Bhowmick NA, "Stromal fibroblasts in cancer initiation and progression" 432 : 332-337, 2004

8 Young AL, "Regional differences in prostaglandin E2metabolism in human colorectal cancer liver metastases" 13 : 92-, 2013

9 지예섭, "Prostaglandin E2 and Interleukin-1β Reduce E-cadherin Expression by Enhancing Snail Expression in Gastric Cancer Cells" 대한의학회 27 (27): 987-992, 2012

10 Na HK, "Peroxisome proliferator-activated receptor γ(PPARγ)ligands as bifunctional regulators of cell proliferation" 66 : 1381-1391, 2003

11 Karnoub AE, "Mesenchymal stem cells within tumour stroma promote breast cancer metastasis" 449 : 557-563, 2007

12 Serini G, "Mechanisms of myofibroblast activity and phenotypic modulation" 250 : 273-283, 1999

13 Palena C, "Influence of IL-8on the epithelial-mesenchymal transition and the tumor microenvironment" 8 : 713-722, 2012

14 Kundu JK, "Inflammation : gearing the journey to cancer" 659 : 15-30, 2008

15 Sugimoto H, "Identification of fibroblast heterogeneity in the tumor microenvironment" 5 : 1640-1646, 2006

16 Schulte J, "Expression of the E-cadherin repressors Snail, Slug and Zeb1in urothelial carcinoma of the urinary bladder : relation to stromal fibroblast activation and invasive behaviour of carcinoma cells" 138 : 847-860, 2012

17 Micke P, "Exploring the tumour environment : cancerassociated fibroblasts as targets in cancer therapy" 9 : 1217-1233, 2005

18 Hugo H, "Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression" 213 : 374-383, 2007

19 Ranger GS, "Elevated cyclooxygenase-2 expression correlates with distant metastases in breast cancer" 24 : 2349-2351, 2004

20 Kalluri R, "EMT : when epithelial cells decide to become mesenchymal-like cells" 119 : 1417-1419, 2009

21 Dohadwala M, "Cyclooxygenase-2-dependent regulation of E-cadherin : prostaglandin E2 induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer" 66 : 5338-5345, 2006

22 Davies G, "Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancer" 9 : 2651-2656, 2003

23 Littlepage LE, "Coevolution of cancer and stromal cellular responses" 7 : 499-500, 2005

24 Mishra PJ, "Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells" 68 : 4331-4339, 2008

25 Mantovani A, "Cancer-related inflammation" 454 : 436-444, 2008

26 Xing F, "Cancer associated fibroblasts(CAFs)in tumor microenvironment" 15 : 166-179, 2010

27 Maeda M, "Cadherin switching : essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition" 118 (118): 873-887, 2005

28 Direkze NC, "Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts" 64 : 8492-8495, 2004

29 Shin SW, "15d-PGJ2 induces apoptosis by reactive oxygen speciesmediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity" 15 : 5414-5425, 2009

30 Scher JU, "15d-PGJ2 : the anti-inflammatory prostaglandin" 114 : 100-109, 2005

31 Surh YJ, "15-Deoxy-Δ12, 14-prostaglandin J2, an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling" 82 : 1335-1351, 2011

32 Kim EH, "15-Deoxy-Δ12, 14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors" 72 : 1516-1528, 2006